Sanofi's high-dose flu vaccine superior to standard dose for elderly

08/27/2013 | Reuters

A clinical trial with about 30,000 participants found that Sanofi's Fluzone High-Dose vaccine offered better protection against influenza than the standard dose in adults 65 and older. Sanofi plans to submit data to the FDA by early next year to support a change in the vaccine's label.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN